TScan Therapeutics, Inc. Common Stock TCRX

$0.78 +0.88% at last close

Recent SEC Filings

FormDescriptionFiledDocument
10-Q 10-Q 2026-08-12 View →
8-K 8-K 2026-08-12 View →
8-K 8-K 2026-06-22 View →
4 4 2026-05-22 View →
8-K 8-K 2026-05-22 View →
4 4 2026-05-22 View →
4 4 2026-05-22 View →
4 4 2026-05-22 View →
4 4 2026-05-22 View →
4 4 2026-05-22 View →
10-Q 10-Q 2026-05-06 View →
8-K 8-K 2026-05-06 View →
DEF 14A DEF 14A 2026-04-17 View →
8-K 8-K 2026-04-02 View →
10-K 10-K 2026-03-04 View →
8-K 8-K 2026-03-04 View →
4 4 2026-01-22 View →
4 4 2026-01-22 View →
4 4 2026-01-22 View →
4 4 2026-01-22 View →
4 4 2026-01-22 View →
8-K 8-K 2026-01-12 View →
4 Insider transaction 2025-12-23 View →
8-K 8-K 2025-11-26 View →
10-Q 10-Q 2025-11-12 View →
8-K 8-K 2025-11-12 View →
8-K 8-K 2025-11-03 View →
8-K 8-K 2025-09-09 View →
8-K 8-K 2025-08-20 View →
10-Q 10-Q 2025-08-12 View →
8-K 8-K 2025-08-12 View →
4 4 2025-07-02 View →
4 4 2025-07-02 View →
4 4 2025-07-02 View →
4 4 2025-07-02 View →
4 4 2025-07-02 View →
4 4 2025-07-02 View →
8-K 8-K 2025-07-02 View →
4 Insider transaction 2025-05-21 View →
DEF 14A DEF 14A 2025-05-14 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$0.78
Market Cap
$52.39 million
52-Week Range
$0.72 – $2.57
Average Volume
658K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.